NYSEMKT: PLXProtalix Biotherapeutics Inc Stock Ownership - Who owns Protalix Biotherapeutics?
Insider buying vs selling
Have Protalix Biotherapeutics Inc insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.
Be the first to know when PLX insiders and whales buy or sell their stock.
PLX Shareholders
What type of owners hold Protalix Biotherapeutics Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Biocell Ltd | 38.24% | 30,442,586 | $46.88M | Insider |
| Phillip Md Et Al Frost | 22.84% | 18,184,566 | $28.00M | Insider |
| Zeev Bronfeld | 20.89% | 16,628,800 | $25.61M | Insider |
| Eyal Sheratzki | 18.17% | 14,466,319 | $22.28M | Insider |
| Camber Capital Management LP | 13.54% | 10,775,000 | $16.59M | Insider |
| Sharon Toussiacohen | 8.24% | 6,556,381 | $10.10M | Insider |
| Marathon Investments Ltd | 8.24% | 6,556,381 | $10.10M | Insider |
| Amos Barshalev | 7.77% | 6,187,726 | $9.53M | Insider |
| Technorov Holdings 1993 Ltd | 7.77% | 6,186,046 | $9.53M | Insider |
| Eli Hurvitz | 6.73% | 5,353,923 | $8.25M | Insider |
PLX vs Biotech Stocks
Protalix Biotherapeutics Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.